» Authors » Farah Mouhanna

Farah Mouhanna

Explore the profile of Farah Mouhanna including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 549
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Holman D, Jones S, Cornett K, Mouhanna F
J Dermatol Nurses Assoc . 2024 Dec; 16(5):173-176. PMID: 39624572
Sunburn during adolescence increases a person's lifetime skin cancer risk. This study examines the association between sports team participation and sunburn prevalence among U.S. high school students. Using cross-sectional data...
2.
Belden M, Reif S, Cooper H, Shilling S, Mouhanna F, Hipp P, et al.
AIDS Care . 2021 Oct; 34(1):60-68. PMID: 34632864
Community-based organizations (CBOs) have been instrumental in addressing the needs of people living with HIV, however, little is known about their efforts to address HIV-related stigma through stigma reduction efforts....
3.
Sangaramoorthy T, Haddix M, Agopian A, Yellin H, Mouhanna F, Abdi H, et al.
AIDS Behav . 2021 Feb; 25(6):1954-1967. PMID: 33537918
Unmet needs can impede optimal care engagement, impacting the health and well-being of people living with HIV (PLWH); yet, whether unmet needs differ by care engagement status is not well...
4.
Mouhanna F, Castel A, Sullivan P, Kuo I, Hoffman H, Siegler A, et al.
Ann Epidemiol . 2020 Sep; 49:1-7. PMID: 32951802
Purpose: Oral emtricitabine/tenofovir disoproxil fumarate was approved for use as pre-exposure prophylaxis (PrEP) by the U.S. Food and Drug Administration in 2012. We used national pharmacy data to examine trends...
5.
Siegler A, Mehta C, Mouhanna F, Mera Giler R, Castel A, Pembleton E, et al.
Ann Epidemiol . 2020 Apr; 45:24-31.e3. PMID: 32336655
Purpose: HIV pre-exposure prophylaxis (PrEP) is highly efficacious, and yet most individuals indicated for it are not currently using it. To provide guidance for health policymakers, researchers, and community advocates,...
6.
Siegler A, Wiatrek S, Mouhanna F, Amico K, Dominguez K, Jones J, et al.
AIDS Behav . 2020 Mar; 24(9):2637-2649. PMID: 32157490
Stigma regarding HIV pre-exposure prophylaxis (PrEP) is commonly implicated as a factor limiting the scale-up of this highly effective HIV prevention modality. To quantify and characterize PrEP stigma, we developed...
7.
Sullivan P, Mouhanna F, Mera R, Pembleton E, Castel A, Jaggi C, et al.
Ann Epidemiol . 2020 Feb; 44:16-30. PMID: 32088073
Purpose: Pre-exposure prophylaxis (PrEP) is a pillar of the US Department of Health and Human Services "Ending the HIV Epidemic" (EHE) initiative in 50 EHE jurisdictions (48 U.S. counties and...
8.
Pokharel Y, Mouhanna F, Schneider A, Rawlings A, Knopman D, Nambi V, et al.
J Am Geriatr Soc . 2019 Jul; 67(11):2353-2361. PMID: 31359423
Objectives: Cardiac troponin T, measured using a high-sensitive assay (hs-cTnT), and N-terminal pro-B-type natriuretic peptide (NT-proBNP) are associated with increased stroke risk and perhaps with cognitive decline. However, few well-designed...
9.
Pokharel Y, Mouhanna F, Nambi V, Virani S, Hoogeveen R, Alonso A, et al.
Neurology . 2019 May; 92(22):e2580-e2593. PMID: 31043469
Objective: To examine the association of specific lipoproteins/inflammatory enzyme with cognitive change. Methods: We examined the association of apolipoprotein B (ApoB), small-dense low-density lipoprotein cholesterol (sdLDL-C), lipoprotein (a) (Lp[a]), and...
10.
Siegler A, Bratcher A, Weiss K, Mouhanna F, Ahlschlager L, Sullivan P
Ann Epidemiol . 2018 Nov; 28(12):858-864. PMID: 30406756
Purpose: HIV pre-exposure prophylaxis (PrEP) is highly effective in preventing HIV transmission. Finding a PrEP provider, however, can be a barrier to accessing care. This study explores the distribution of...